Last Close
16.88 $
Jul 3, 26
Market Cap
4 B $
Q2 2025 (TTM)
52-Week Range
%-29.5
%58.5
-0.98
-1.01
%-33.5
-%66.0
1M
+38.4%
3M
+30.3%
6M
+48.6%
YTD
+50.7%
1Y
-29.5%
3Y
+50.7%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P/ASX 200 index is measured in its own currency.
TLX last closed at 16.88 $ (Jul 3, 26). Price data is refreshed after every trading day.
TELIX Pharmaceuticals Ltd (TLX) has a market capitalization of approximately 4 B $ as of the latest reported period.
Key peers of TELIX Pharmaceuticals Ltd include Tarsus Pharmaceuticals Inc, Nurix Therapeutics Inc, Trevi Therapeutics Inc, Cogent Biosciences Inc, Disc Medicine Inc.. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.